क्यूआर कोड

ChAdOx1 nCoV-19 Immunogenicity and Immunological Response Following COVID-19 Infection in Patients Receiving Maintenance Hemodialysis

Patients with end-stage renal disease (ESRD) receiving hemodialysis (HD) were found to have a decreased immune response following mRNA COVID-19 immunization. ChAdOx1 nCoV-19 was a promising COVID-19 vaccine that performed well in the general population, but the evidence on immunogenicity in ESRD wit...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Wisit Prasithsirikul, Tanawin Nopsopon, Phanupong Phutrakool, Pawita Suwanwattana, Piyawat Kantagowit, Wannarat Pongpirul, Anan Jongkaewwattana, Krit Pongpirul
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: MDPI AG 2022-06-01
श्रृंखला:Vaccines
विषय:
COVID-19
SARS-CoV-2
ChAdOx1 nCoV-19
hemodialysis
ESRD
vaccines
ऑनलाइन पहुंच:https://www.mdpi.com/2076-393X/10/6/959
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन